Selvita S.A.
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational re… Read more
Selvita S.A. (SLV) - Total Assets
Latest total assets as of September 2025: zł610.80 Million PLN
Based on the latest financial reports, Selvita S.A. (SLV) holds total assets worth zł610.80 Million PLN as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Selvita S.A. - Total Assets Trend (2015–2024)
This chart illustrates how Selvita S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Selvita S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Selvita S.A.'s total assets of zł610.80 Million consist of 19.4% current assets and 80.6% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 3.5% |
| Accounts Receivable | zł79.56 Million | 12.4% |
| Inventory | zł6.86 Million | 1.1% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł26.95 Million | 4.2% |
| Goodwill | zł89.64 Million | 14.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Selvita S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Selvita S.A.'s current assets represent 19.4% of total assets in 2024, a decrease from 74.4% in 2015.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, down from 44.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 3.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 14.0% of total assets.
Selvita S.A. Competitors by Total Assets
Key competitors of Selvita S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Selvita S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Selvita S.A. generates 0.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Selvita S.A. is currently not profitable relative to its asset base.
Selvita S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 1.05 | 4.35 |
| Quick Ratio | 0.88 | 0.99 | 4.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-6.16 Million | zł 6.01 Million | zł 110.12 Million |
Selvita S.A. - Advanced Valuation Insights
This section examines the relationship between Selvita S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.51 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | zł642.09 Million |
| Market Capitalization | $129.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Selvita S.A.'s assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Selvita S.A.'s assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Selvita S.A. (2015–2024)
The table below shows the annual total assets of Selvita S.A. from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł642.09 Million | +0.92% |
| 2023-12-31 | zł636.26 Million | +8.78% |
| 2022-12-31 | zł584.91 Million | +25.36% |
| 2021-12-31 | zł466.59 Million | +113.25% |
| 2020-12-31 | zł218.80 Million | +140.73% |
| 2019-12-31 | zł90.89 Million | +25.22% |
| 2018-12-31 | zł72.58 Million | +51.41% |
| 2017-12-31 | zł47.94 Million | -46.21% |
| 2016-12-31 | zł89.12 Million | +36.60% |
| 2015-12-31 | zł65.24 Million | -- |